[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Spiegelman, 1963 - Google Patents

Treatment of diabetes insipidus with synthetic vasopressin

Spiegelman, 1963

Document ID
8433509714171143300
Author
Spiegelman A
Publication year
Publication venue
JAMA

External Links

Snippet

THE CHRONIC NATURE of diabetes insipidus necessitates an indefinite course of treatment. Hormonal substitution is obviously the preferred form of therapy. Nevertheless some patients cannot tolerate the natural vasopressor substance or, for other reasons are …
Continue reading at jamanetwork.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators; Reciprocating systems for treatment of body fluids, e.g. single needle systems for haemofiltration, pheris
    • A61M1/28—Peritoneal dialysis; Other peritoneal treatment, e.g. oxygenation
    • A61M1/285—Catheters therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof

Similar Documents

Publication Publication Date Title
Day et al. Peritoneal dialysis in children. Review of 8 years' experience.
Spiegelman Treatment of diabetes insipidus with synthetic vasopressin
Muth Diuretic response to furosemide in the presence of renal insufficiency
FELDMAN et al. Prolonged paresis following gallamine: a case report
Kurtzman Renal tubular acidosis: a constellation of syndromes
ALEXANDER et al. Chlorothiazide derivatives for diabetes insipidus?
Schreiner et al. The patient with chronic renal failure and surgery
Geiger et al. Acute pulmonary insufficiency: treatment in Vietnam casualties
KAISER et al. Intravenous infusion of ascitic fluid
Seedat High-dose furosemide (Lasix) in renal insufficiency
Chew et al. Continuous atropine infusion in the management of organophosphorus insecticide poisoning
PARTENHEIMER et al. PRACTICAL CONTROL OF FLUID AND ELECTROLYTE BALANCE IN CARBON TETRACHLORIDE NEPHROSIS: Report of Cases
Litchman et al. Injuries to the medial meniscus in the aging patient
Merrill Reversible renal failure
PAINE Preoperative and postoperative treatment of patients with lesions of the small intestine and of the colon
RU2290201C1 (en) Method for treating acute purulent-destructive pulmonary diseases
Keitzer Treatment of acute uremia
Snodgrass et al. Idiopathic hypoparathyroidism with small-bowel X-ray features of sprue, without steatorrhea
Monro The complications of gastric and duodenal ulcer
Fang Peritoneal catheter perforating into the colon—a serious complication of peritoneal dialysis
Shropshire et al. Suppression of Menstruation: A Hygienic Measure in the Care of Mentally Retarded Patients
Kendall et al. Temperate sprue.
Riddell et al. Studies in Portal Hypertension
Sinha et al. 1195: CHICKEN POX WITH SEVERE SEPSIS WITH MULTI-ORGAN DYSFUNCTION AND SEVERE RHABDOMYOLYSIS
Bentley et al. 1194: NEUROTOXICITY ASSOCIATED WITH CEFEPIME DURING IHD AND THE EFFECT OF CVVHDF ON DRUG CLEARANCE